Literature DB >> 2173469

Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.

D A Spandidos1, S Zakinthinos, C Petraki, F Sotsiou, M Yiagnisis, A M Dimopoulos, C Roussos, J K Field.   

Abstract

Ras p21 and myc p62 expression has been examined immunohistochemically in seventy specimens of bronchial carcinomas. Both ras and myc oncoproteins were found to be overexpressed at a higher frequency in non small cell carcinomas (squamous cell carcinomas and adenocarcinomas) compared to the small cell carcinoma specimens; however only myc p62 overexpression was found to be statistically significant. Also, ras p21 oncoprotein expression was frequently overexpressed in adenocarcinomas compared to squamous cell carcinomas (p less than 0.05). Overexpression of c-myc p62 was found to correlate with poorly differentiated squamous cell carcinomas compared to the well and moderately differentiated tumors. The results of this study indicate that both the ras and myc oncogenes are important in the progression of bronchial carcinomas.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173469

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas.

Authors:  M Volm; P Drings; W Wodrich
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

2.  Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas.

Authors:  M Volm; W Rittgen; P Drings
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.